By Order of May 2, 2005, the Supreme Court designated all New Jersey state court Accutane litigation as mass tort and assigned that litigation for centralized management to Atlantic County Superior Court for handling by the then mass tort judge in that vicinage. The litigation is presently assigned to Superior Court Judge John C. Porto. Judge Porto has reported to the Administrative Director of the Courts that all remaining active cases have been resolved and that MCL designation and centralized management of that litigation should therefore be concluded.
Accordingly, pursuant to the prov1s10ns of Court Rule 4:38A and Directive #02-19, "Multicounty Litigation Guidelines and Criteria for Designation (Revised)," this Notice is to advise of the proposed conclusion of the MCL designation and centralized management of the New Jersey state-court Accutane litigation.
Anyone wishing to comment on or object to this application should provide such comments or objections in writing, with relevant supporting documentation, by March 14, 2022 to:
Glenn A. Grant
Administrative Director of the Courts
Attention: Proposed Conclusion of Accutane MCL Hughes Justice Complex
P.O. Box 037
Trenton, New Jersey 08625-0037
Comments/objections may also be sent by email to Comments.mailbox@njcourts.gov.
A copy of Judge Porto's report and recommendation is posted with this Notice on the Judiciary website at www.njcourts.gov in the Multicounty Litigation Information Center http://www.njcourts.gov/attorneys/mcl/index.html).
Document Date: Feb. 7, 2022
Publish Date: Feb. 9, 2022